Adaptation and validation of a quantitative vanA/vanB DNA screening assay on a high-throughput PCR system

Katja Giersch,Konstantin Tanida,Anna Both,Dominik Nörz,Denise Heim,Holger Rohde,Martin Aepfelbacher,Marc Lütgehetmann
DOI: https://doi.org/10.1038/s41598-024-54037-5
IF: 4.6
2024-02-14
Scientific Reports
Abstract:Vancomycin resistant enterococci (VRE) are a leading cause of ICU-acquired bloodstream infections in Europe. The bacterial load in enteral colonization may be associated with a higher probability of transmission. Here, we aimed to establish a quantitative vanA/vanB DNA real-time PCR assay on a high-throughput system. Limits of detection (LOD), linear range and precision were determined using serial bacterial dilutions. LOD was 46.9 digital copies (dcp)/ml for vanA and 60.8 dcp/ml for vanB . The assay showed excellent linearity between 4.7 × 10 1 and 3.5 × 10 5 dcp/ml ( vanA ) and 6.7 × 10 2 and 6.7 × 10 5 dcp/ml ( vanB ). Sensitivity was 100% for vanA and vanB , with high positive predictive value (PPV) for vanA (100%), but lower PPV for vanB (34.6%) likely due to the presence of vanB DNA positive anerobic bacteria in rectal swabs. Using the assay on enriched VRE broth vanB PPV increased to 87.2%. Quantification revealed median 2.0 × 10 4 dcp/ml in PCR positive but VRE culture negative samples and median 9.1 × 10 4 dcp/ml in VRE culture positive patients (maximum: 10 7 dcp/ml). The automated vanA/B _UTC assay can be used for vanA/vanB detection and quantification in different diagnostic settings and may support future clinical studies assessing the impact of bacterial load on risk of infection and transmission.
multidisciplinary sciences
What problem does this paper attempt to address?